» Articles » PMID: 10522604

Psychometric Validation of a Constipation Symptom Assessment Questionnaire

Overview
Publisher Informa Healthcare
Specialty Gastroenterology
Date 1999 Oct 16
PMID 10522604
Citations 147
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Clinical management of constipation is complicated by the lack of a gold standard for evaluation of symptoms. A constipation symptom assessment instrument, the PAC-SYM, was developed to address the patient perspective on the disorder. Instrument content was based on literature review and results of focus groups.

Methods: Two hundred and sixteen patients at nine sites participated in a 6-week psychometric evaluation of the PAC-SYM. The final instrument contained 12 items assigned to 3 subscales: stool symptoms, rectal symptoms, and abdominal symptoms. The psychometric properties of this final instrument were assessed.

Results: Internal consistency and test-retest reliability of the final instrument was high (Cronbach's alpha = 0.89; intraclass correlation = 0.75). Concurrent validity was supported by the correlation with both subject and investigator constipation severity ratings (r= 0.68 and 0.72, respectively; P < 0.0001). Scores were moderately correlated with instruments measuring quality of life. Comparison of treatment responders with nonresponders showed the ability of the instrument to differentiate between groups on the basis of clinical severity (t = -6.12, P < 0.0001 ). Scores changed significantly over time among responders, indicating instrument responsiveness.

Conclusions: The PAC-SYM is internally consistent, reproducible under stable conditions, valid, and responsive to change and provides a comprehensive means to assess the effectiveness of treatment for constipation.

Citing Articles

Associations Between Dietary Patterns and the Occurrence of Hospitalization and Gastrointestinal Disorders-A Retrospective Study of COVID-19 Patients.

Hawrylkowicz V, Stasiewicz B, Korus S, Krauze W, Rachubinska K, Grochans E Nutrients. 2025; 17(5).

PMID: 40077670 PMC: 11901568. DOI: 10.3390/nu17050800.


Naloxegol for the Treatment of Opioid-Induced Constipation in Patients with Cancer Pain: A Pooled Analysis of Real-World Data.

Sabate J, Beato-Zambrano C, Cobo M, Lemaire A, Montesarchio V, Serna-Montros J Cancers (Basel). 2025; 17(5).

PMID: 40075711 PMC: 11898930. DOI: 10.3390/cancers17050865.


Evaluation of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Subjects With Rosacea.

Nelson J, Rizzo J, Greene R, Fahlstrom K, Troost J, Helfrich Y Cureus. 2024; 16(10):e72363.

PMID: 39583431 PMC: 11585968. DOI: 10.7759/cureus.72363.


Prevalence, risk factors, impact and management of constipation among adults in Urumqi, China: a cross-sectional survey.

Shi L, Shi L, Wei M, Zhang M, Zhang Y, Li J Front Nutr. 2024; 11:1451527.

PMID: 39555186 PMC: 11563834. DOI: 10.3389/fnut.2024.1451527.


Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson's disease: results from an open label single-arm study.

Andreozzi V, Cuoco S, Balestrieri M, Fierro F, Ferrara N, Erro R Sci Rep. 2024; 14(1):23095.

PMID: 39367119 PMC: 11452401. DOI: 10.1038/s41598-024-74400-w.